What is the evidence so far: cytology and blood tests

P. Rabbitts (Cambridge, United Kingdom)

Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Session: A sceptical look at lung cancer screening
Session type: Symposium
Number: 4417

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Rabbitts (Cambridge, United Kingdom). What is the evidence so far: cytology and blood tests. Annual Congress 2005 - A sceptical look at lung cancer screening

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Screening for lung cancer
Source: Eur Respir Mon; 2009: 44: 57–70
Year: 2009

Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002



Early detection of lung cancer: role of biomarkers
Source: Eur Respir J 2003; 21: 36S-44S
Year: 2003



Screening
Source: Eur Respir J 2003; 21: 3S-15S
Year: 2003



The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018

Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology
Source: Eur Respir Mon; 2010: 48: 272–296
Year: 2010

EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer
Source: Eur Respir J 2006; 28: 1186-1189
Year: 2006



Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010

Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012

DR-70, A promising biomarker for the detection of lung cancer>
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002



Is there any diagnostical significance of blood analyses in patients with lung cancer?
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

What you have to show before you do a screening programme
Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Year: 2005

Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Source: Eur Respir J 2010; 35: 146-151
Year: 2010



Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature
Source: Eur Respir J 2009; 33: 1206-1215
Year: 2009



An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Airspace dimension test (ADT): A novel technique for diagnosis of the peripheral lung
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014


Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014